Xinyu Cheng

Yu Zhang, Changhao Pan, Wenxiang Guo et al.

The scarcity of high-quality and multi-task singing datasets significantly hinders the development of diverse controllable and personalized singing tasks, as existing singing datasets suffer from low quality, limited diversity of languages and singers, absence of multi-technique information and realistic music scores, and poor task suitability. To tackle these problems, we present GTSinger, a large global, multi-technique, free-to-use, high-quality singing corpus with realistic music scores, designed for all singing tasks, along with its benchmarks. Particularly, (1) we collect 80.59 hours of high-quality singing voices, forming the largest recorded singing dataset; (2) 20 professional singers across nine widely spoken languages offer diverse timbres and styles; (3) we provide controlled comparison and phoneme-level annotations of six commonly used singing techniques, helping technique modeling and control; (4) GTSinger offers realistic music scores, assisting real-world musical composition; (5) singing voices are accompanied by manual phoneme-to-audio alignments, global style labels, and 16.16 hours of paired speech for various singing tasks. Moreover, to facilitate the use of GTSinger, we conduct four benchmark experiments: technique-controllable singing voice synthesis, technique recognition, style transfer, and speech-to-singing conversion. The demos can be found at http://aaronz345.github.io/GTSingerDemo/. We provide the dataset and the code for processing data and conducting benchmarks at https://huggingface.co/datasets/AaronZ345/GTSinger and https://github.com/AaronZ345/GTSinger.

Zeyu Deng, Lihui Wang, Zixiang Kuai et al.

In vivo diffusion tensor imaging (DTI) is a promising technique to investigate noninvasively the fiber structures of the in vivo human heart. However, signal loss due to motions remains a persistent problem in in vivo cardiac DTI. We propose a novel motion-compensation method for investigating in vivo myocardium structures in DTI with free-breathing acquisitions. The method is based on an invertible Wavelet Scattering achieved by means of Convolutional Neural Network (WSCNN). It consists of first extracting translation-invariant wavelet scattering features from DW images acquired at different trigger delays and then mapping the fused scattering features into motion-compensated spatial DW images by performing an inverse wavelet scattering transform achieved using CNN. The results on both simulated and acquired in vivo cardiac DW images showed that the proposed WSCNN method effectively compensates for motion-induced signal loss and produces in vivo cardiac DW images with better quality and more coherent fiber structures with respect to existing methods, which makes it an interesting method for measuring correctly the diffusion properties of the in vivo human heart in DTI under free breathing.

Li Wang, Lihui Wang, Qijian Chen et al.

We proposed a novel convolutional restricted Boltzmann machine CRBM-based radiomic method for predicting pathologic complete response (pCR) to neoadjuvant chemotherapy treatment (NACT) in breast cancer. The method consists of extracting semantic features from CRBM network, and pCR prediction. It was evaluated on the dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data of 57 patients and using the area under the receiver operating characteristic curve (AUC). Traditional radiomics features and the semantic features learned from CRBM network were extracted from the images acquired before and after the administration of NACT. After the feature selection, the support vector machine (SVM), logistic regression (LR) and random forest (RF) were trained to predict the pCR status. Compared to traditional radiomic methods, the proposed CRBM-based radiomic method yielded an AUC of 0.92 for the prediction with the images acquired before and after NACT, and an AUC of 0.87 for the pretreatment prediction, which was increased by about 38%. The results showed that the CRBM-based radiomic method provided a potential means for accurately predicting the pCR to NACT in breast cancer before the treatment, which is very useful for making more appropriate and personalized treatment regimens.